Prolong Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

 Prolong Pharmaceuticals, a clinical stage biopharmaceutical company focusing on developing products to treat several diseases and their debilitating comorbidities associated with reduced quality of life, increased medical cost, and significant mortality, announced today that Glenn Kazo, its president and chief operating officer, will present an overview of the company at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco.